These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1342293)
1. On the role of coagulation and fibrinolysis in atherosclerosis. Juhan-Vague I; Collen D Ann Epidemiol; 1992 Jul; 2(4):427-38. PubMed ID: 1342293 [TBL] [Abstract][Full Text] [Related]
2. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Idell S Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443 [TBL] [Abstract][Full Text] [Related]
3. Disturbed Laminar Blood Flow Causes Impaired Fibrinolysis and Endothelial Fibrin Deposition In Vivo. Glise L; Larsson P; Jern S; Borén J; Levin M; Ny T; Fogelstrand P; Bergh N Thromb Haemost; 2019 Feb; 119(2):223-233. PubMed ID: 30602198 [TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
7. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
8. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms. Fay WP; Eitzman DT; Shapiro AD; Madison EL; Ginsburg D Blood; 1994 Jan; 83(2):351-6. PubMed ID: 8286735 [TBL] [Abstract][Full Text] [Related]
9. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women. DeSouza CA; Jones PP; Seals DR Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [TBL] [Abstract][Full Text] [Related]
11. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction. Gram J Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835 [TBL] [Abstract][Full Text] [Related]
12. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury. Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447 [TBL] [Abstract][Full Text] [Related]
13. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system. Sindet-Pedersen S Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633 [TBL] [Abstract][Full Text] [Related]
14. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids. Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017 [TBL] [Abstract][Full Text] [Related]
15. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M J Endocrinol Invest; 2008 Jun; 31(6):537-41. PubMed ID: 18591887 [TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Sjöland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):846-52. PubMed ID: 10712412 [TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation and fibrinolysis in arteriosclerosis]. Hoffmeister HM; Heller W; Seipel L Z Kardiol; 1999 May; 88(5):315-23. PubMed ID: 10413853 [TBL] [Abstract][Full Text] [Related]
18. Physiological consequences of loss of plasminogen activator gene function in mice. Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887 [TBL] [Abstract][Full Text] [Related]
19. D-dimer and fibrinolysis in patients with various degrees of atherosclerosis. Panchenko E; Dobrovolsky A; Davletov K; Titaeva E; Kravets A; Podinovskaya J; Karpov Y Eur Heart J; 1995 Jan; 16(1):38-42. PubMed ID: 7737219 [TBL] [Abstract][Full Text] [Related]
20. [From fibrinogen to fibrin and its dissolution]. Juhan-Vague I; Hans M Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]